Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DR26F8YXV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,193
Award facts
- Contract value 100% obligated
- $19,192.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,192.92 to AmerisourceBergen Drug Corp for the supply of Kesimpta 20 mg/0.4 ml pen injections on November 3, 2025, with completion expected by November 4, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills similar delivery orders through open competition with the DLA Medical Supply Chain. The company's contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Kesimpta is a specialty pharmaceutical product used in neurological treatment, consistent with AmerisourceBergen's demonstrated expertise in supplying specialized healthcare commodities for military medical applications.
Quick answers
Who was awarded contract SPE2DR26F8YXV?
SPE2DR26F8YXV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26F8YXV worth?
The government has obligated $19,193 on SPE2DR26F8YXV.
Is contract SPE2DR26F8YXV an order under another contract?
Yes. SPE2DR26F8YXV is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YXV competed?
The extent of competition for SPE2DR26F8YXV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award